Andrea D'Ambrogio, PhD - Head of Business Development

Andrea D’Ambrogio obtained a PhD in Molecular Medicine from the Open University – International Centre for Genetic Engineering in Trieste, Italy, working on the molecular basis of neurodegenerative diseases. He then was a Postdoc at University of Massachusetts where he published seminal papers on miRNAs and cancer and developed novel methods for the NGS analysis of RNAs. In 2013 he joined Horizon Discovery in Cambridge UK where he led the development of multiple off-the-shelf molecular diagnostic products and custom projects for major sequencing companies and big pharmas. In 2016 he joined Diatech Pharmacogenetics, in Italy, where he was responsible for R&D and Innovation. He led the launch of the NGS-based line of CE-IVD products for both Illumina and IonTorrent platforms and of the Dx NGS Analysis Software. In early 2018 Andrea joined Exosomics to lead Business Development.